1. Comparative effects of HIV protease inhibitors (PIs) on lipid accumulation and glucose uptake in human and mouse adipocytes;Bahador;AIDS,2006
2. Injection site reactions with the HIV-1 fusion inhibitor enfuvirtide;Ball;J. Am. Acad. Dermatol.,2003
3. Abacavir use and risk of acute myocardial infarction and cerebrovascular disease in the HAART era;Bedimo,2009
4. Benson, C., Zheng, E., Ribaudo, H., Koletar, S., Collier, A., Smurzynski, M., Bosch, R., Bastow, B., Schouten, J., ACTG A5001/ALLRT Protocol Team, 2009. No association of abacavir (ABC) Use with risk of myocardial infarction (MI) or severe cardiovascular disease events (SCVD): results from ACTG A5001/ALLRT. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, #721.
5. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors;Birkus;Antimicrob. Agents Chemother.,2002